tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Revenue

Compare
923 Followers

Immunovant Revenue

Immunovant had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2025, Immunovant had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
362
Market Cap
$5.43B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
Mar 31, 2024
Mar 31, 2023
Mar 31, 2022
Mar 31, 2021
Mar 31, 2020
Mar 31, 2019
Mar 31, 2018